Paxlovid is a medicine used for treating COVID-19 in adults who do not require supplemental oxygen and who are at increased risk of the disease becoming severe. Paxlovid contains two active substances, PF-07321332 and ritonavir, in two different tablets.
Therapeutic Indication
N/A
Therapeutic Area (MeSH)
N/AATC Code
J05AE30
ATC Item
nirmatrelvir and ritonavir
Pharmacotherapeutic Group
N/A
Active Substance (Summary)
N/AINN / Common Names
N/AEMA Name
Paxlovid
Medicine Name
Paxlovid
Aliases
N/ANo risk management plan link.